PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences (Nasdaq:OCLS) today announced that it has entered into definitive agreements with institutional and other accredited investors with respect to the private placement of up to 1,263,500 shares of its common stock at a purchase price of $8.00 per share, for expected gross proceeds of $10.1 million, before payment of placement agent commissions and offering expenses. Investors also will receive warrants to purchase an aggregate of up to 417,000 shares of common stock at an exercise price of $9.50 per share. The warrants are subject to weighted average anti-dilution protection.
